SLC25A3 and hypertrophic cardiomyopathy: Notably, a homozygous mutation in SLC25A3 has been identified as cause of reduced mitochondrial ATP production in muscle, leading to mitochondrial phosphate carrier deficiency with lactic acidosis, hypertrophic cardiomyopathy and muscle hypotonia in humans [32].